PACBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.84+0.11 (+6.36%)
Close on Oct 19, 2026
- Market cap
- $571.61M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Pacific Biosciences Of California statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Laboratory Analytical Instruments companies for comparison
Valuation
| Measure | Pacific Biosciences Of California | Industry median |
|---|---|---|
| Market Cap | $571.93M | $230.55M |
| Enterprise Value | $335.06M | $202.97M |
| PS Ratio | 3.59 | 3.11 |
Enterprise value
| Measure | Pacific Biosciences Of California | Industry median |
|---|---|---|
| EV / Sales | 2.10 | 2.92 |
Income (trailing twelve months)
| Measure | Pacific Biosciences Of California | Industry median |
|---|---|---|
| Revenue | $159.27M | $102.39M |
| Gross Profit | $57.95M | $60.36M |
| Operating Income | -$133.04M | -$4.31M |
| Pretax Income | -$130.56M | -$2.26M |
| Net Income | -$131.39M | -$6.57M |
| EBITDA | -$133.04M | -$1.98M |
| EPS (Diluted) | -$0.43 | -$0.07 |
Margins
| Measure | Pacific Biosciences Of California | Industry median |
|---|---|---|
| Gross Margin | 36.4% | 55.1% |
| Operating Margin | -83.5% | -6.04% |
| Pretax Margin | -82.0% | -4.11% |
| Profit Margin | -82.5% | -10.5% |
| EBITDA Margin | -83.5% | -2.67% |
| FCF Margin | -77.5% | -0.30% |
Returns
| Measure | Pacific Biosciences Of California | Industry median |
|---|---|---|
| Return on Equity (ROE) | -929.3% | -19.2% |
| Return on Assets (ROA) | -16.7% | -13.3% |
| Return on Capital Employed (ROCE) | -19.5% | -9.07% |
Growth
| Measure | Pacific Biosciences Of California | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 2.02% | 8.85% |
| Revenue Growth (3Y CAGR) | 7.64% | 7.08% |
| Revenue Growth (5Y CAGR) | 15.2% | 11.8% |
Balance sheet
| Measure | Pacific Biosciences Of California | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $236.87M | $37.33M |
| Net Cash (Debt) | $236.87M | $3.92M |
| Net Cash Per Share | $0.76 | $0.28 |
| Equity (Book Value) | -$33.21M | $57.36M |
| Book Value Per Share | -$0.11 | $2.81 |
| Tangible Book Value | -$364.06M | $10.71M |
| Working Capital | $269.83M | $54.64M |
Financial position
| Measure | Pacific Biosciences Of California | Industry median |
|---|---|---|
| Current Ratio | 4.92 | 2.50 |
| Quick Ratio | 3.89 | 1.54 |
| Interest Coverage | -18.15 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Pacific Biosciences Of California | Industry median |
|---|---|---|
| Operating Cash Flow | -$118.05M | -$653.46K |
| Capital Expenditures | -$5.37M | -$3.69M |
| Free Cash Flow | -$123.42M | -$835.02K |
| FCF Per Share | -$0.40 | -$0.02 |
Efficiency
| Measure | Pacific Biosciences Of California | Industry median |
|---|---|---|
| Asset Turnover | 0.20 | 0.59 |
| Inventory Turnover | 1.76 | 2.21 |
| Revenue Per Employee | $328.39K | $322.57K |
| Profits Per Employee | -$270.90K | -$51.88K |
| Employee Count | 485 | 185 |
Dividends and yields
| Measure | Pacific Biosciences Of California | Industry median |
|---|---|---|
| Earnings Yield | -23.0% | -6.91% |
| FCF Yield | -21.6% | -0.56% |
| Dividend Yield | 0.00% | 0.81% |
| Shareholder Yield | 0.00% | 0.80% |
| Dividend Per Share | $0.00 | $0.72 |
| Years of Dividend Growth | 0 | 0 |
Shares
| Measure | Pacific Biosciences Of California | Industry median |
|---|---|---|
| Shares Outstanding | 310,831,000 | 44,856,700 |
| Shares Change (YoY) | 0.89% | 3.35% |
| Shares Change (QoQ) | 0.10% | 0.27% |
| Float | 297,199,000 | 37,097,900 |
| Shares Held by Insiders | 4.39% | 10.6% |
| Shares Held by Institutions | 61.5% | 63.5% |
Taxes
| Measure | Pacific Biosciences Of California | Industry median |
|---|---|---|
| Income Tax | $827.00K | $1.52M |
Scores
| Measure | Pacific Biosciences Of California | Industry median |
|---|---|---|
| Altman Z-Score | -4.62 | 1.95 |
| Piotroski F-Score | 4 | 5 |
Calculated by StockData from Pacific Biosciences Of California's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.